Steele C, Hagopian WA, Gitelman S et al (2004) Insulin secretion in type 1 diabetes. Diabetes 53:426–433

Article  PubMed  CAS  Google Scholar 

Bhatt MP, Lee YJ, Jung SH, Kim YH, Hwang JY, Han ET et al (2016) C-peptide protects against hyper- glycemic memory and vascular endothelial cellapoptosis. J Endocrinol 231:97–108. https://doi.org/10.1530/JOE-16-0349

Article  PubMed  CAS  Google Scholar 

Jeon HY, Moon CH, Kim EB, Sayyed ND, Lee AJ, Ha KS (2023) Simultaneous attenuation of hyperglycemic memory-induced retinal, pulmonary, and glomerular dysfunctions by proinsulin C-peptide in diabetes. BMC Med 13:35–49. https://doi.org/10.1186/s12916-023-02760-7

Article  CAS  Google Scholar 

Souto SB, Campos JR, Fangueiro JF, Silva AM, Cicero N, Lucarini M et al (2020) Multiple cell signalling pathways of human proinsulin C-Peptide in vasculopathy protection. Int J Mol Sci 18:636–645. https://doi.org/10.3390/ijms21020645

Article  CAS  Google Scholar 

Wahren J, Johansson BL, Wallberg-Henriksson H, Linde B, Fernqvist-Forbes E, Zierath JR (1996) C-peptide revisited—New physiological effects and therapeutic implications. J Int Med 240:115–124. https://doi.org/10.1046/j.1365-2796.1996.19841000.x

Article  CAS  Google Scholar 

Marx N, Walcher D, Raichle C, Aleksic M, Bach H, Grüb M et al (2004) C-peptide colocalizes with macrophages in early arteriosclerotic lesions of diabetic subjects and induces monocyte chemotaxis in vitro. Arterioscler Thromb Vasc Biol 24:540–545. https://doi.org/10.1161/01.ATV.0000116027.81513.68

Article  PubMed  CAS  Google Scholar 

Marques R, Fontaine M, Rogers J (2004) C-peptide: much more than a byproduct of insulinbiosynthesis. Pancreas 29(3):231–238. https://doi.org/10.1097/00006676-200410000-00009

Article  PubMed  CAS  Google Scholar 

Boscolo F, Faggionato E, Welch AA, Farahani RA, Egan AM, Vella A et al (2025) A new C-peptideminimalmodel to assess β-cell responsiveness to glucagon in individuals with and without type 2 diabetes. Am J Physiol Endocrinol Metab 328(3):E470–E477. https://doi.org/10.1152/ajpendo.00424.2024

Article  PubMed  CAS  Google Scholar 

Venugopal SK, Mowery ML, Jialal I (2023) Biochemistry C Peptide: StatPearls [Internet]

Leighton E, Sainsbury CA, Jones GC (2017) A practical review of C-peptide testing in diabetes. Diabetes Ther 8(3):475–487

Article  PubMed  PubMed Central  CAS  Google Scholar 

Xiao Y, Yu B, Chao C, Wang S, Hu D, Wu C et al (2024) Chinese expert consensus on blood lipid management in patients with diabetes. J Transl Int Med 12:325–343. https://doi.org/10.2478/jtim-2024-0014

Article  PubMed  PubMed Central  Google Scholar 

Borén J, Taskinen MR, Olofsson SO, Levin M (2013) Ectopic lipid storage and insulin resistance: a harmful relationship. J Intern Med 274(1):25–40. https://doi.org/10.1111/joim.12071

Article  PubMed  CAS  Google Scholar 

Ginsberg HN, Packard CJ, Chapman MJ, Borén J, Aguilar-Salinas CA, Averna M et al (2021) Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society. Eur. Heart J. 42:4791–4806. https://doi.org/10.1093/eurheartj/ehab551

Article  PubMed  PubMed Central  CAS  Google Scholar 

Chait A, Ginsberg HN, Vaisar T, Heinecke JW, Goldberg IJ, Bornfeldt KE (2020) Remnants of the triglyceride-rich lipoproteins, diabetes, and cardiovascular disease. Diabetes 69:508–516. https://doi.org/10.2337/dbi19-0007

Article  PubMed  PubMed Central  CAS  Google Scholar 

Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F (2008) The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord 6:299–304. https://doi.org/10.1089/met.2008.0034

Article  PubMed  CAS  Google Scholar 

Tahapary DL, Pratisthita LB, Fitri NA, Marcella C, Wafa S, Kurniawan F et al (2022) Challenges in the diagnosis ofinsulin resistance: focusing on the role of HOMA-IR and tryglyceride/glucose index. Diabetes Metab Syndr 16:102581. https://doi.org/10.1016/j.dsx.2022.102581

Article  PubMed  CAS  Google Scholar 

Wu X, Qiu W, Yang H, Chen YJ, Liu J, Zhao G (2024) Associations of the triglyceride-glucose index and atherogenic index of plasma with the severity of new-onset coronary artery disease in different glucose metabolic states. Cardiovasc Diabeto.l 23:76. https://doi.org/10.1186/s12933-024-02163-9

Article  CAS  Google Scholar 

Cai X, Xu M, Chen J, Mao Y, Hu J, Li L et al (2024) Association between the trajectories of the atherogenic index of plasma and prediabetes progression to diabetes: a retrospective cohort study. Diabetes Metab Syndr Obes 6:4689–4699. https://doi.org/10.2147/DMSO.S481578

Article  Google Scholar 

Chinese Diabetes S (2018) National guidelines for the prevention and control of diabetes in primary care. Zhonghua Nei Ke Za Zhi 57:885–893. https://doi.org/10.3760/cma.j.issn.0578-1426.2018.12.003

Article  Google Scholar 

Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB et al (2022) )IDF diabetes atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract 183:109076–109119. https://doi.org/10.1016/j.diabres.2021.109119

Article  Google Scholar 

Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI et al (2009)A new equation to estimate glomerularfiltration rate. Ann Intern Med 150:604–61210.7326/0003-4819-150-200905050-00006

Ramdas Nayak VK, Satheesh P, Shenoy MT et al (2022)Triglyceride glucose (TyG) index: A surrogate biomarker of insulin resistance. J Pak Med Assoc 72:986–988. https://doi.org/10.47391/JPMA.22-63

Araki E, Goto A, Kondo T, Noda M, Noto H, Origasa H et al (2020) Japanese clinical practice guideline for diabetes 2019. J Diabetes Investig 11:1020–1076. https://doi.org/10.1111/jdi.13306

Article  PubMed  PubMed Central  Google Scholar 

Yan S-T, Sun J, Gu Z-Y, Miao XY, Ma LC, Sun BR et al (2022) The bidirectional association of C-peptide with cardiovascular risk in nondiabetic adults and patients with newly diagnosed type 2 diabetes mellitus: a retrospective cohort study. Cardiovasc Diabetol 21:201. https://doi.org/10.1186/s12933-022-01636-z

Article  PubMed  PubMed Central  CAS  Google Scholar 

Wahren J, Larsson C (2015) C-peptide: new findings and therapeutic possibilities. Diabet Res Clin Pract 107:309–319. https://doi.org/10.1016/j.diabres.2015.01.016

Article  CAS  Google Scholar 

Esze R, Barna S, Fülöp P, Kempler P, Mikó M, Páll D et al (2024) C-peptide: an essential ally in microvascular complications of type 2 diabetes mellitus and obesity. Diabetol Metab Syndr 16:211. https://doi.org/10.1186/s13098-024-01454-1

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bhatt MP, Lim Y-C, Ha K-S (2014) C-peptide replacement therapy as an emerging strategy for preventing diabetic vasculopathy. Cardiovasc Res 104:234–44. https://doi.org/10.1093/cvr/cvu211

Article  PubMed  CAS  Google Scholar 

Forst T, Kunt T, Wilhelm B et al (2008) Role of C-peptide in the regulation of microvascular blood flow. Exp Diabet Res 176245. https://doi.org/10.1093/cvr/cvu211

Huang Y, Wang Y, Liu C, Zhou Y, Wang X, Cheng B et al (2022) C-peptide, glycaemic control, and diabetic complications in type 2 diabetes mellitus: a real-world study. Diabetes Metab Res Rev 38:e3514. https://doi.org/10.1002/dmrr.3514

Article  PubMed  CAS  Google Scholar 

Fang F, Wang N, Liu X, Wang W, Sun J, Li H et al (2023) )Value of C-peptide-based insulin resistance index forevaluating correlation between insulin resistance and serum uric acid level in individuals undergoing health examination. Nan Fang Yi Ke Da Xue Xue Bao 43:1509–1514 Chinese.doi:. https://doi.org/10.12122/j.issn.1673-4254.2023.09.08

Article  PubMed  CAS  Google Scholar 

Chen J, Huang Y, Liu C, Chi J, Wang Y, Xu L (2023) The role of C-peptide in diabetes and its complications: an updated review. Front Endocrinol (Lausanne) 14:1256093. https://doi.org/10.3389/fendo.2023.1256093

Article  PubMed  Google Scholar 

Marx N (2008) C-peptide as a mediator of lesion development in early diabetes—a novelhypothesis. Trends Cardiovasc Med 18:67–71. https://doi.org/10.1016/j.tcm.2007.12.005